XOMA

Down 30%, Worth a Look

moreView todays social media effects on XOMAView the latest stocks trending across Twitter. Click to view dashboardSee who XOMA is hiring next, click here to view […]

4:26 pm XOMA halted with news pending

moreView todays social media effects on XOMAView the latest stocks trending across Twitter. Click to view dashboardSee who XOMA is hiring next, click here to view […]

Orphan Drug Status for XOMA’s Gevokizumab

moreView todays social media effects on XOMAView the latest stocks trending across Twitter. Click to view dashboardSee who XOMA is hiring next, click here to view […]

XOMA Receives Orphan Drug Designation From U.S. FDA for Pyoderma Gangrenosum

[GlobeNewswire] – BERKELEY, Calif. — XOMA Corporation , a leader in the discovery and development of therapeutic antibodies, announced today gevokizumab, the Company’s IL-1 beta modulating antibody, has been granted Orphan … moreView todays social media effects on XOMAView the latest stocks trending across Twitter. Click to view dashboardSee who XOMA is hiring next, click here to view […]

XOMA to Present at Upcoming Investor Conferences

[GlobeNewswire] – BERKELEY, Calif. — XOMA Corporation , a leader in the discovery and development of therapeutic antibodies, announced today members of its management team are scheduled to present at three upcoming investor … moreView todays social media effects on XOMAView the latest stocks trending across Twitter. Click to view dashboardSee who XOMA is hiring next, click here to view […]

XOMA Announces Fourth Quarter and Full-Year Financial Results Conference Call

[at noodls] – BERKELEY, Calif., March 4, 2013 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced the Company will host a conference call … moreView todays social media effects on XOMAView the latest stocks trending across Twitter. Click to view dashboardSee who XOMA is hiring next, click here to view […]

XOMA to Present at Upcoming Investor Conferences

[at noodls] – BERKELEY, Calif., Feb. 21, 2013 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today that management is scheduled to … moreView todays social media effects on XOMAView the latest stocks trending across Twitter. Click to view dashboardSee who XOMA is hiring next, click here to view […]